Dr. Chris Gentile, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 22 S Greeley Ave, Chappaqua, NY 10514 Phone: 914-238-5600 Fax: 914-238-5617 |
Foresight Eye Care Optometry Llc Optometrist Medicare: Medicare Enrolled Practice Location: 26 S Greeley Ave Ste 4, Chappaqua, NY 10514 Phone: 646-241-4868 |
Alec Perlson Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 26 S Greeley Ave, Chappaqua, NY 10514 Phone: 914-238-3030 |
Alec J Perlson, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 26 S Greeley Ave, Chappaqua, NY 10514 Phone: 914-238-3030 Fax: 914-238-5757 |
Eye Gallery Of Chappaqua Optometrist Medicare: Not Enrolled in Medicare Practice Location: 22 S Greeley Ave, Chappaqua, NY 10514 Phone: 914-238-5600 Fax: 914-238-5617 |
Saara Hashmi, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 26 S Greeley Ave Ste 4, Chappaqua, NY 10514 Phone: 914-238-3030 Fax: 914-238-5757 |
News Archive
A newly published paper describes and evaluates the Indiana University Center for Health Innovation and Implementation Science, a novel virtual laboratory employing the tools of implementation science to improve population health, lower costs of its delivery and prepare the future health care transformational leaders.
Scarab Genomics, a pioneer in the world of E. coli genomics and production strains, and Lonza, a world leader in biopharmaceutical development and production, announced today the companies have entered into a preferred marketing and sales agreement for Scarab Genomics' Clean Genome E. coli. Financial details of the contract were not disclosed.
Supplementing children's diets with fish oil, enrolling them in quality preschool, and engaging them in interactive reading all turn out to be effective ways to raise a young child's intelligence, according to a new report published in Perspectives on Psychological Science, a journal of the Association for Psychological Science.
A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction. The late breaking study is presented in a Hot Line session today at ESC Congress 2021 and published in the New England Journal of Medicine.
› Verified 2 days ago